Zherdev V P, Kolyvanov G B, Litvin A A, Sariev A K, Viglinskaia A O, Gekkiev B I, Grigor'ev A M, Gorlov V V
Eksp Klin Farmakol. 2010 Jan;73(1):23-5.
The pharmacokinetics of dihydroquercetin (DHQ) in the forms of parent substance and a new liposomal formulation (Flamena D) have been studied in rats upon single peroral administration in a dose of 50 mg/kg. DHQ concentration after enzymatic hydrolysis in the blood plasma was determined by HPLC with UV detection. The elimination half-life of DHQ introduced in the form of Flamena D was about T(1/2) = 1.3 h. The relative bioavailability of DHQ after the administration of Flamena D amounted to 159% in comparison to that of the parent substance of DHQ.
已在大鼠中研究了二氢槲皮素(DHQ)母体物质和新脂质体制剂(Flamena D)单次口服50 mg/kg剂量后的药代动力学。采用高效液相色谱-紫外检测法测定血浆中酶解后的DHQ浓度。以Flamena D形式引入的DHQ的消除半衰期约为T(1/2)=1.3小时。与DHQ母体物质相比,给予Flamena D后DHQ的相对生物利用度达159%。